SPY363.67+1.01 0.28%
DIA299.24+0.50 0.17%
IXIC12,205.85+111.44 0.92%

Qualigen Therapeutics Yesterday Reported Q2 EPS $(0.41), Sales $837.71K

Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.41) per share. The company reported $837.71 thousand in sales this quarter.

· 11/13/2020 09:10
Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.41) per share. The company reported $837.71 thousand in sales this quarter.